一名表皮生长因子受体基因突变（p.R776H）患者患有多种肺癌，并携带不同的体细胞表皮生长因子受体基因突变。

IF 3.3 3区医学 Q2 ONCOLOGY

Clinical lung cancer Pub Date : 2024-07-01 DOI:10.1016/j.cllc.2024.04.007

Iacopo Petrini , Rossella Bruno , Iosè Di Stefano , Vittorio Aprile , Stylianos Korasidis , Eleonora Pardini , Antonio Chella , Greta Alì

引用次数: 0

摘要

-在切除的各种具有磨玻璃/鳞状上皮特征的结节中，存在不同的表皮生长因子受体突变，这表明存在多灶性原发肿瘤。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

A patient with a Germline (p.R776H) EGFR Mutation With Multiple Lung Cancers Harboring Different Somatic EGFR Mutations

•
There are not standard guidelines for the selection and treatment of patients with synchronous multiple nodules with ground glass/lepidic features.
•
The presence of different EGFR mutations in the various resected nodules with ground glass/lepidic features suggests the existence of multifocal primary tumors.
•
The results suggest the possibility that a germline mutation in an oncogene could facilitate the development of a tumor with additional mutations in the same oncogene.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Clinical lung cancer 医学-肿瘤学

CiteScore

7.00

自引率

2.80%

发文量

159

审稿时长

24 days

期刊介绍： Clinical Lung Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lung cancer. Clinical Lung Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of lung cancer. The main emphasis is on recent scientific developments in all areas related to lung cancer. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.